JPRN-jRCT1041230068
Recruiting
Phase 2
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancer - NUPAT-10
Ebata Tomoki0 sites50 target enrollmentAugust 9, 2023
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- pancreatic cancer
- Sponsor
- Ebata Tomoki
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) diagnosed as pancreatic cancer by imiging studies
- •2\) patients without distant metastasis (M0\)
- •3\) resectable pancreatic cancer
- •4\) CA19\-9 \>100U/ml
- •5\) age of 20\-80
- •6\) PS (ECOG) 0 or 1
- •7\) initial treatment for the disease
- •8\) without other malignancies
- •9\) normal oral ingestion
- •10\) without major organ failures
Exclusion Criteria
- •1\) serious allergy for any drug
- •2\) active other malignancies
- •3\) active infectious disease
- •4\) neuropathy (\>Grade 2\)
- •5\) administered with atanazavir
- •6\) bowel obstruction or paresis
- •7\) uncontrolable acites or pleural effusion
- •8\) uncontrolable diabetes, hypertention, chirrosis, renal failure, ischemic cardiac disease, interstitial pneumonia
- •9\) pregnant or lactating women
- •10\) unable to join the clinical trial due to psychological condition
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
Completed
Phase 1
The phaseI,II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with locally-advanced pancreatic cancerlocally-advanced pancreatic cancerJPRN-UMIN000016630Hiroshima University60
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with nab-paclitaxel followed by FEC in patitents with operable breast cancerbreast cancerJPRN-UMIN000030692kyushu Breast Cancer Study Group40